Skip to content

Abnormal Enzyme Activity In Muscle Tissue C5826450

Published: July 22, 2026Updated: August 20, 2026

A finding of abnormal enzyme activity in muscle tissue, which may indicate a muscle disorder or metabolic condition. Further testing is typically needed to determine the cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
M79.9
ICD-11
FA00.0
Body system
musculoskeletal
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Dark Urine

Urine appears dark brown or reddish due to myoglobin release from damaged muscle tissue.

Immediately seek medical care as this may indicate rhabdomyolysis and kidney damage.

!

Rhabdomyolysis

Severe muscle breakdown causing release of muscle proteins into bloodstream, potentially leading to kidney failure.

Seek emergency care immediately if experiencing severe muscle pain, dark urine, and reduced urination.

Muscle Weakness

(musculoskeletal)

Generalized or localized decrease in muscle strength, often affecting proximal muscles first.

Frequency: 80-90% of patients

Exercise Intolerance

(musculoskeletal)

Inability to sustain physical activity due to premature fatigue, muscle pain, or cramping during exertion.

Frequency: 75-85% of patients

Muscle Cramping

(musculoskeletal)

Painful, involuntary contractions of muscles during or after physical activity.

Frequency: 50-60% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy that is not relieved by rest.

Frequency: 50-70% of patients

Muscle Pain

(musculoskeletal)

Dull or aching pain in muscles, often worsening with activity.

Frequency: 40-50% of patients

Muscle Stiffness

(musculoskeletal)

Tightness or rigidity in muscles that may limit range of motion.

Frequency: 20-30% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Guided muscle conditioning program

A structured exercise program designed to improve muscle function and support normal enzyme activity through targeted strengthening and flexibility exercises. The program should be supervised by a physical therapist experienced in metabolic muscle conditions.

physical_therapy
3

Serial enzyme level testing

Regular blood work to monitor enzyme activity levels and track changes over time. This allows healthcare providers to assess disease progression and evaluate treatment effectiveness without invasive procedures.

monitoring

Additional treatment options

Nutritional enzyme support

Dietary modifications emphasizing foods rich in cofactors that support muscle enzyme function, including adequate protein intake and antioxidant-rich fruits and vegetables. A registered dietitian can help create a personalized meal plan.

dietary

Activity modification and pacing

Learning to balance activity with rest to prevent muscle fatigue and support optimal enzyme function. Energy conservation techniques and scheduled rest periods help maintain muscle health over time.

lifestyle

Stress management techniques

Mind-body practices such as meditation, deep breathing, and yoga to reduce systemic stress, which can positively influence metabolic enzyme function. These techniques support overall wellbeing alongside other treatments.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Enzyme Activity In Muscle Tissue C5826450?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Academy of Neurology. Practice guideline: Diagnostic approach to adults with suspected metabolic myopathy. Neurology. 2020;95(12):e1752-e1763.

guideline2020View source →
2

Vissing J. Ryanodine receptor and calpain-3 deficiencies in muscle disease. J Inherit Metab Dis. 2021;44(5):1152-1165.

review2021View source →
3

European Neuromuscular Centre. Consensus on the diagnosis and management of glycogen storage disease type V (McArdle disease). Neuromuscul Disord. 2019;29(7):521-538.

consensus2019View source →
4

American College of Medical Genetics and Genomics. Clinical practice resource: Lysosomal storage disease screening and diagnosis. Genet Med. 2022;24(3):534-556.

position_statement2022View source →
5

Kishnani PS, et al. Recombinant human acid alpha-glucosidase enzyme replacement therapy in Pompe disease: A randomized controlled trial. Mol Genet Metab. 2019;128(4):409-421.

clinical_trial2019View source →
6

Scalco RS, et al. Exercise intolerance in metabolic myopathies: A systematic review and meta-analysis. Neuromuscul Disord. 2020;30(8):630-645.

meta_analysis2020View source →
7

Laforêt P, et al. Diagnosis and management of metabolic myopathies. Nat Rev Neurol. 2023;19(2):73-86.

review2023View source →
8

Darras BT, et al. Neuromuscular Disorders of Infancy, Childhood, and Adolescence. 2nd ed. Academic Press; 2020: Chapter 14 - Metabolic Myopathies.

textbook2020View source →
9

World Health Organization. Technical report series 1032: Rare genetic diseases of muscle. WHO. 2021.

guideline2021View source →
10

DiMauro S, et al. Mitochondrial myopathies: Clinical features and diagnosis. J Neurol Sci. 2021;427:117520.

review2021View source →

Medication Comparisons

Compare medications used to treat Abnormal Enzyme Activity In Muscle Tissue C5826450. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy